Please assess the completion status of the following clinical trial:

Trial Title: G-EO Gait Rehabilitation Training in Progressive Multiple Sclerosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18-64 years~* Confirmed diagnosis of Primary or Secondary Progressive Multiple Sclerosis (this will be confirmed by the referring physician)~* EDSS 4.0-7.522~* Stable course of disease-modifying therapy over the past 6 months~* Asymptomatic (i.e., no underlying cardiovascular disease)~* Physician approval for exercise~* Willingness to visit the IU Health Neurosciences Center for testing and training~Exclusion Criteria:~* Pregnancy~* Current use of dalfampridine (Ampyra®)~* Conventional physical therapy or G-EO training within the past 6 months~* Height \<1m or \>2m~* Body weight \>150 kg~* Contraindications to G-EO gait training (e.g., bone instability)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- Conventional Physical Therapy (Type: ACTIVE_COMPARATOR): Conventional physical therapy (CPT): CPT sessions will involve a 3-5 minute warm-up, stretching, progressive strength training exercises, and gait and balance training.40-43 Additional strategies for home exercises, energy conservation, fall prevention, and appropriate assistive devices (i.e., orthotics) will be provided.
- End-Effector Robotic Training (Type: EXPERIMENTAL): G-EO training: Using the G-EO System, participants will be secured with the appropriate sized harness and attached to an overhead body-weight support system, with feet secured to pressure sensitive footplates. Each session will begin with a 3-5 minute warm-up in the continuous passive mode (cadence \~40-45 steps/minute). The participant will then be transitioned into the adaptive training phase for practicing repetitive floor walking and stair climbing for up to 30 minutes. During this phase, the force produced by the robot is modulated to support the effort of the patient in producing a typical walking pattern.

Based on this trial design, predict the completion outcome and termination type (if applicable).